Siemens to Reduce Stake in Healthineers to Minority Position — Update

By Nina Kienle


Siemens said it would deconsolidate its roughly 67% stake in Siemens Healthineers, positioning itself as a focused technology company.

The German industrial conglomerate said Wednesday that it plans to transfer 30% of Siemens Healthineers shares to Siemens AG shareholders by way of a spinoff. Cutting its stake in Healthineers will allow the group greater flexibility in allocating capital while maintaining a minority interest in the "attractive business," Siemens said.

Siemens's current stake in Healthineers is worth around 33.9 billion euros ($39.26 billion), according to LSEG data.

In the medium term, Siemens aims to reduce the shareholding to a financial asset, it said.

The spinoff is a further step in simplifying its portfolio, Siemens said.

Siemens listed the medical-equipment unit in 2018, keeping an initial 85% share. It has since then gradually cut its shareholding in the business. Earlier this year it sold 2% for around 1.45 billion euros, taking its stake to 73%. In April, Siemens acquired science-software company Dotmatics for $5.1 billion, financed primarily through the sale of shares in listed companies, including Siemens Healthineers, it said at the time.

"By giving up the controlling majority in Siemens Healthineers, we are focusing on a highly synergistic Siemens portfolio," Siemens Chief Executive Roland Busch said on Wednesday.

"This is a logical next step in executing our strategy of combining the real and the digital worlds, focusing on accelerated profitable growth of our digital businesses, connected and software defined hardware and industrial [artificial intelligence]," Busch said.

The spinoff transaction remains subject to shareholder approval of both companies. Frankfurt-listed Siemens Healthineers will host its capital-markets day on Nov. 17, at which it will outline its midterm strategy and financial targets.

Separately, Siemens said Veronika Bienert will succeed current Chief Financial Officer Ralf Thomas at some point in fiscal 2026, which began Oct. 1.


Write to Nina Kienle at nina.kienle@wsj.com


(END) Dow Jones Newswires

November 12, 2025 14:14 ET (19:14 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center